🇪🇸 Ahora disponible en español  |  Now available in Spanish →
Licensed Providers FDA-Regulated Pharmacy Delivered to Your Door

The weight loss conversation has changed. The clinical approach should too.

GLP-1 medications like semaglutide and tirzepatide are transforming weight management. But a prescription alone isn't a protocol. At Truventa, every patient gets a provider-guided plan that addresses hormones, metabolism, and overall health — not just appetite.

HIPAA Compliant
All 50 States
GLP-1 Education

Understanding GLP-1 Medications

GLP-1 receptor agonists are the most significant advancement in weight management in decades. Here's what you need to know — and what most clinics won't tell you.

All prescriptions are at the sole discretion of your licensed provider and are not guaranteed.

What Are GLP-1 Receptor Agonists?

GLP-1 (glucagon-like peptide-1) receptor agonists mimic a naturally occurring hormone that regulates appetite, blood sugar, and gastric emptying. When you eat, your body releases GLP-1 to signal satiety. These medications amplify that signal, helping you feel full sooner and reducing the constant background noise of hunger that makes sustainable weight loss so difficult.

But here's what matters: GLP-1s aren't magic. They're a clinical tool. And like any tool, they work best when they're part of a broader protocol — one that accounts for your hormonal profile, metabolic health, body composition, and long-term goals.

Semaglutide vs. Tirzepatide

Semaglutide (the active ingredient in Ozempic® and Wegovy®) targets the GLP-1 receptor. In the STEP 1 clinical trial of FDA-approved Wegovy® (not compounded semaglutide), participants achieved average weight loss of approximately 15% of body weight over 68 weeks. It's well-studied, effective, and the most widely prescribed GLP-1 medication for weight management.

Tirzepatide (the active ingredient in Mounjaro® and Zepbound®) is a dual GIP/GLP-1 receptor agonist. By targeting two pathways instead of one, in the SURMOUNT-1 clinical trial of FDA-approved Mounjaro® (not compounded tirzepatide), participants achieved average weight loss of approximately 21% of body weight. For many patients, this dual mechanism translates to more significant results.

Your licensed provider will recommend the right medication based on your health history, metabolic markers, and treatment goals. There's no one-size-fits-all answer — which is exactly why you need a doctor, not an algorithm.

Key Differences

  • Semaglutide: Single GLP-1 receptor target, ~15% avg in STEP 1 trial*, weekly injection
  • Tirzepatide: Dual GIP/GLP-1 target, ~21% avg in SURMOUNT-1 trial*, weekly injection

    *Trial results are from studies of FDA-approved brand-name medications and may not apply to compounded versions, which have not been studied in equivalent clinical trials.

  • Oral GLP-1: Daily tablet option for patients who prefer not to inject
  • Both are dosed gradually over weeks to minimize side effects
  • Both require physician monitoring for safety and efficacy
Your Options

Brand-Name & Compounded Options

We offer both brand-name and compounded GLP-1 medications. Your provider will help you choose the right path based on your goals, budget, and health profile.

Compounded Semaglutide

Starting at $179/mo

Contains semaglutide, prepared by FDA-regulated 503B compounding pharmacies. Compounded semaglutide is not FDA-approved. Includes medication, provider consultations, ongoing monitoring, and free shipping.

  • Weekly subcutaneous injection
  • Gradual dose titration over 4-8 weeks
  • Ongoing care team support
  • No insurance required

Compounded Tirzepatide

Starting at $199/mo

Contains tirzepatide, prepared by FDA-regulated 503B compounding pharmacies. Compounded tirzepatide is not FDA-approved. Dual-action GIP/GLP-1 pathway. Full protocol support included.

  • Dual receptor targeting for enhanced results
  • Weekly subcutaneous injection
  • Physician-guided dose optimization
  • All-inclusive pricing — no hidden fees

Brand-Name Wegovy® / Zepbound®

Insurance Accepted

FDA-approved brand-name medications. We'll verify your insurance coverage for free and handle prior authorizations so you don't have to.

  • FDA-approved medications
  • Free insurance verification
  • Prior authorization support
  • Provider consultations included

Oral GLP-1 Tablets

Ask Your provider

For patients who prefer a daily oral option over weekly injections. Your licensed provider will discuss whether an oral GLP-1 is appropriate for your treatment plan.

  • No injections required
  • Daily oral administration
  • Physician evaluation required
  • May be combined with other therapies
The Hormonal Connection

Weight Loss & Hormones: The Feedback Loop

Excess body fat doesn't just affect how you look. It actively disrupts the hormones that regulate metabolism, energy, and body composition.

The Testosterone + Weight Loss Connection

Body fat contains an enzyme called aromatase that converts testosterone into estrogen. The more body fat you carry, the more testosterone gets converted — creating a vicious cycle: low testosterone leads to increased fat storage, which leads to even lower testosterone.

This is why many patients who come to us for weight loss also have suboptimal testosterone levels. And it's why we check your hormones as part of our weight loss protocol. A GLP-1 alone won't fix a hormonal imbalance — but the right combination of therapies can break the cycle.

Healthy Body Composition: Why It Matters

One of the most under-discussed risks of rapid weight loss is losing lean body mass alongside fat. Research shows that up to 30-40% of weight lost on calorie restriction alone can come from lean tissue. This matters because lean tissue is metabolically active — losing it slows your metabolism and makes weight regain more likely.

Our protocol builds in body composition from day one. This may include protein intake guidance, resistance training recommendations, regular body composition monitoring, and hormonal health screening — not just the number on the scale.

Monitoring & Labs

  • Metabolic Panel: Fasting glucose, HbA1c, insulin, lipid panel
  • Hormone Panel: Total & free testosterone, estradiol, thyroid (TSH, Free T3/T4)
  • Inflammation: CRP, liver enzymes (ALT/AST)
  • Body Composition: Weight, waist circumference, body composition tracking
  • Follow-ups: Regular check-ins at weeks 4, 8, 12, and quarterly after
Our Approach

Your 3-Phase Weight Loss Protocol

This isn't a quick fix. It's a physician-designed system built for lasting results.

Phase 01

Comprehensive Baseline

Before prescribing anything, we need to understand your metabolic and hormonal starting point. Your licensed provider orders a full panel and reviews your complete health history.

  • Complete metabolic panel
  • Full hormone panel
  • Thyroid function
  • Body composition assessment
  • Health history & goal setting
Phase 02

Personalized Protocol

Based on your labs and health profile, Your provider builds a customized treatment plan. This may include GLP-1 therapy, hormonal optimization, nutrition guidance, and more.

  • GLP-1 medication selection & dosing
  • Hormonal optimization if needed
  • Body composition monitoring
  • Nutrition & lifestyle recommendations
  • Side effect management plan
Phase 03

Ongoing Optimization

Weight loss isn't linear. Your provider adjusts your protocol based on real data — not guesswork. Regular labs, check-ins, and dose adjustments keep you on track.

  • Regular physician check-ins
  • Dose titration & adjustment
  • Follow-up lab monitoring
  • Body composition tracking
  • Long-term maintenance planning
What to Expect

Your Weight Loss Timeline

Every patient is different. Here's a realistic overview of what many patients report experiencing during their first six months.

Weeks 1–4: Initiation

You begin at the lowest dose. Many patients report noticing reduced appetite within the first 1-2 weeks. Some experience mild nausea that typically resolves as your body adjusts. Average weight loss: 3-6 lbs. Your provider checks in to assess tolerance and side effects.

Weeks 4–8: Dose Titration

Your dose is gradually increased based on tolerance and response. Appetite suppression becomes more consistent. Cravings — especially for high-sugar, high-fat foods — begin to decrease significantly. Average cumulative weight loss: 8-14 lbs.

Months 2–3: Steady Progress

You're now on your therapeutic dose. Weight loss becomes more consistent — typically 1-2 lbs per week. Energy levels often improve. Clothes start fitting differently. Lab markers (glucose, lipids) may begin to improve. Follow-up labs ordered.

Months 3–6: Acceleration

This is where significant changes become visible. Many patients experience significant weight reduction by month 6. Blood pressure, cholesterol, and blood sugar markers often show meaningful improvement. Your provider may adjust the protocol based on your progress.

Month 6+: Maintenance & Optimization

You and Your provider discuss long-term strategy. Some patients continue GLP-1 therapy at a maintenance dose. Others may taper off with a structured plan. The goal is always sustainable results — not just a number on a scale. Ongoing monitoring ensures you keep your progress.

Honest Conversation

What Happens When You Stop

We believe you deserve the full picture — not just the marketing version. Here's what the research says about stopping GLP-1 medications, and what we do about it.

The Reality

Studies show that many patients regain a significant portion of lost weight within 12 months of stopping GLP-1 therapy — especially if no other changes were made. This isn't a failure of the medication. It's biology. The hormonal and metabolic signals that drive appetite and fat storage don't disappear just because you lost weight.

Our Approach

  • We build sustainable habits during treatment, not after
  • Hormonal optimization (especially testosterone) helps maintain metabolic rate
  • Body composition protocols protect against metabolic slowdown
  • Structured taper plans — not abrupt discontinuation
  • Long-term low-dose maintenance is an option for many patients
  • Ongoing monitoring catches weight regain early
FAQ

Weight Loss — Frequently Asked Questions

Results vary by individual, but clinical trials of FDA-approved brand-name medications showed average weight loss of approximately 15% with semaglutide (STEP 1) and 21% with tirzepatide (SURMOUNT-1). These results may not apply to compounded versions when combined with lifestyle modifications. Your licensed provider will set realistic expectations based on your starting point and health profile.
The most common side effects are gastrointestinal: nausea, constipation, diarrhea, and occasional vomiting. These are typically mild and most common during dose titration. They usually resolve within 2-4 weeks. Our gradual dosing protocol is specifically designed to minimize these effects. Your provider is always available to adjust your plan if side effects are bothersome.
Compounded medications contain the same active pharmaceutical ingredient and are prepared by FDA-regulated 503B compounding pharmacies. However, compounded medications are NOT the same as their brand-name counterparts — they may differ in formulation, inactive ingredients, and delivery method. Brand-name medications (Wegovy®, Zepbound®) are FDA-approved. Compounded versions are not FDA-approved but are legally prescribed and prepared under regulatory oversight.
Yes — in fact, GLP-1 medications were originally developed for Type 2 diabetes management. However, if you have diabetes, your treatment requires additional monitoring. Your licensed provider will coordinate your GLP-1 therapy with your existing diabetes management plan and adjust as needed. If you take insulin or sulfonylureas, dosing may need to be modified to prevent hypoglycemia.
Most GLP-1 medications are administered as a once-weekly subcutaneous injection using a small, thin needle — similar to what's used for insulin. Most patients report that it's virtually painless after the first time. If you prefer not to inject, oral GLP-1 tablets may be an option — discuss this with Your provider during your consultation.
This is a legitimate concern with any weight loss program. Research shows that rapid weight loss can result in significant lean tissue loss. Our protocol specifically addresses this through nutritional optimization, protein intake guidance, resistance training recommendations, and body composition monitoring — not just tracking weight on a scale.
Treatment duration varies. Some patients use GLP-1 medications for 6-12 months and then taper off with a structured maintenance plan. Others benefit from long-term, lower-dose therapy. Your licensed provider will discuss your options based on your progress, goals, and metabolic response. We never rush patients off medication — and we're transparent about what the research shows regarding weight regain.
Brand-name medications (Wegovy®, Zepbound®) may be covered by your insurance. We offer free insurance verification and handle prior authorizations on your behalf. Compounded medications are self-pay starting at $179/mo for semaglutide and $199/mo for tirzepatide — everything included, no hidden fees.

Ready to start your weight loss journey?

Join patients who chose provider-guided GLP-1 therapy over quick fixes. Starting at $179/mo, everything included.

Start Your Free Assessment

Prescriptions issued at provider discretion and not guaranteed.

No credit card required·Takes 5 minutes·100% confidential

Truventa Medical is a technology platform that connects patients with independent licensed healthcare providers through OpenLoop Health. Truventa does not directly provide medical services, prescribe medications, or establish a doctor-patient relationship. All clinical decisions are made by your licensed provider.